Skip to content
★ Sign in to follow
JL

Judy Lewent

Board Director
GlaxoSmithKline plc
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 29 Jul 2020 for GlaxoSmithKline plc, €14k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Judy Lewent: trading record in brief

Judy Lewent is a declared insider of GlaxoSmithKline plc, with filings sourced from RNS (LSE). The record holds 6 filings, for trades running from 7 February 2018 to 29 July 2020.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 29 July 2020: a share grant of €14k, in GlaxoSmithKline plc. Publication is fast: at least half of the trades appear on RNS (LSE) on the same day. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to Judy Lewent

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    16,499 USD15FCA-NSM
    404.181 shares@ US$40.82100.0% of flowN/AISIN US37733W1053FCA-NSM:3671412-7
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    18,482 USD12FCA-NSM
    394.248 shares@ US$46.8854.4% of flowN/AISIN US37733W1053FCA-NSM:LSE20200205161501_3485422_20200331164939523_4518-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    18,482 USD0FCA-NSM
    454.447 shares@ US$40.67n/aISIN US37733W1053FCA-NSM:LSE20190501151148_14059820_20200326185143207_28739-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    18,482 USD0FCA-NSM
    470.648 shares@ US$39.27n/aISIN US37733W1053FCA-NSM:LSE20190206122044_13960527_20200326185112577_23728-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    21,326 USD0FCA-NSM
    515.863 shares@ US$41.34n/aISIN US37733W1053FCA-NSM:LSE20180725161500_13731434_20200330111420045_5006-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    21,326 USD0FCA-NSM
    589.11 shares@ US$36.20n/aISIN US37733W1053FCA-NSM:LSE20180207131918_13525081_20200330111413524_21321-7

6 of 6 declarations